X

Vertex Pharmaceuticals Inc (VRTX): Q4 2019 Earnings Snapshot

—  Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) reported earnings of $1.70 per share in the fourth-quarter 2019, vs. $1.20 per share expected. 

— Total revenue rose 63% to $1.41 billion, vs. $1.01 billion expected. 

— For FY20, company expects total product revenues of $5.1 to $5.3 billion.

— VRTX stock ended Thursday’s regular trading session down 0.9%. 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Related Post